Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-032626

Chief Financial Officer bought 1,550 shares at $16.25 ($25,188)

From the SEC's structured data for this filing

Trades in this filing

Radhakrishnan Karthik · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-28 Purchase : show line 1 in the form +1,550 $16.25 $25,188 1,550 D
Open-market purchases · 1,550 sh · avg $16.25 · $25,188
Loading xslF345X05/rdgdoc.xml…